Comparative Pharmacology
Head-to-head clinical analysis: LIPOSYN II 10 versus NUTRILIPID 10.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LIPOSYN II 10 versus NUTRILIPID 10.
LIPOSYN II 10% vs NUTRILIPID 10%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Provides essential fatty acids (linoleic and linolenic) and calories for patients requiring parenteral nutrition; fatty acids are incorporated into cell membranes and serve as precursors for prostaglandins.
Nutrilipid 10% is a fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of calories. It serves as a component of parenteral nutrition, supplying triglycerides that are metabolized to free fatty acids and glycerol for energy production and cellular functions.
Intravenous infusion; maximum daily dose of 2.5 g/kg (25 mL/kg) provided as part of parenteral nutrition, typically administered over 12-24 hours.
Intravenous infusion, 1-2 g/kg/day (0.5-1 g/kg/day for 10% emulsion), not to exceed 2.5 g/kg/day. Initial rate 0.5-1 mL/min for first 15-30 minutes, then increase to maximum of 125 mL/hour.
None Documented
None Documented
18–24 hours for clearance of infused triglycerides; terminal elimination half-life of soybean oil emulsion particles is approximately 30 minutes for particles <1 µm, but longer for larger particles (up to several hours); clinical context: prolonged half-life in renal/hepatic impairment.
Terminal elimination half-life: approximately 0.5-1 hour for the triglyceride component in healthy adults; clinically, clearance depends on infusion rate and metabolic capacity, with prolonged half-life in hypertriglyceridemia.
Renal: negligible; biliary/fecal: negligible; metabolized in tissues (e.g., muscle, adipose) via beta-oxidation and re-esterification; CO2 production via tricarboxylic acid cycle accounts for majority of elimination.
Renal: negligible; biliary/fecal: not applicable as lipid emulsion is metabolized; elimination primarily via lipoprotein lipase-mediated clearance from plasma.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion